Literature DB >> 14963128

Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication.

Rajnish Kaushik1, Lee Ratner.   

Abstract

The matrix domain (MA) is important for targeting of human immunodeficiency virus type 1 Gag assembly to the plasma membrane, envelope incorporation into virions, preintegration complex import into the nucleus, and nuclear export of viral RNA. Myristylation and phosphorylation are key regulatory events for MA function. Previous studies have indicated that MA phosphorylation at serine (Ser) residues is important for viral replication. This study defines the molecular mechanisms of virus particle assembly and infectivity through a detailed study of the role of MA serine phosphorylation. We show that the combined mutation of Ser residues at positions 9, 67, 72, and 77 impairs viral infectivity in dividing and nondividing cells, although the assembly of these Ser mutant viruses is comparable to that of wild-type virus. This defect can be rescued by pseudotyping these mutant viruses with vesicular stomatitis virus G protein, suggesting that these serine residues are critical in an early postentry step of viral infection. The phosphorylation level of MA in defective mutant viruses was severely reduced compared to that of the wild type, suggesting that phosphorylation of Ser-9, -67, -72, and -77 is important for an early postentry step during virus infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963128      PMCID: PMC369234          DOI: 10.1128/jvi.78.5.2319-2326.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.

Authors:  O K Haffar; S Popov; L Dubrovsky; I Agostini; H Tang; T Pushkarsky; S G Nadler; M Bukrinsky
Journal:  J Mol Biol       Date:  2000-06-02       Impact factor: 5.469

2.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

4.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

5.  Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix.

Authors:  Tatyana Dorfman; Elena Popova; Massimo Pizzato; Heinrich G Göttlinger
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.

Authors:  A Ono; J M Orenstein; E O Freed
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.

Authors:  M Pirounaki; N A Heyden; M Arens; L Ratner
Journal:  J Virol Methods       Date:  2000-03       Impact factor: 2.014

9.  The HIV-TSG101 interface: recent advances in a budding field.

Authors:  Eric O Freed
Journal:  Trends Microbiol       Date:  2003-02       Impact factor: 17.079

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  17 in total

1.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

2.  Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay.

Authors:  Suzanne Pontow; Brooke Harmon; Nancy Campbell; Lee Ratner
Journal:  Virology       Date:  2007-07-19       Impact factor: 3.616

Review 3.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

4.  Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix.

Authors:  Ajay K Bhatia; Nancy Campbell; Antonito Panganiban; Lee Ratner
Journal:  Virology       Date:  2007-08-13       Impact factor: 3.616

5.  Reverse transcription complex: the key player of the early phase of HIV replication.

Authors:  Sergey Iordanskiy; Michael Bukrinsky
Journal:  Future Virol       Date:  2007-01-01       Impact factor: 1.831

6.  A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.

Authors:  Laura Brandano; Mario Stevenson
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

7.  Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.

Authors:  Ajay K Bhatia; Rajnish Kaushik; Nancy A Campbell; Suzanne E Pontow; Lee Ratner
Journal:  Virology       Date:  2008-12-06       Impact factor: 3.616

8.  Deletions in the fifth alpha helix of HIV-1 matrix block virus release.

Authors:  Bridget Sanford; Yan Li; Connor J Maly; Christian J Madson; Han Chen; You Zhou; Michael Belshan
Journal:  Virology       Date:  2014-09-15       Impact factor: 3.616

9.  Mutations that mimic phosphorylation of the HIV-1 matrix protein do not perturb the myristyl switch.

Authors:  Jamil S Saad; Andrew Kim; Ruba H Ghanam; Amanda K Dalton; Volker M Vogt; Zhibin Wu; Wuyuan Lu; Michael F Summers
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

10.  Reconstitution of retroviral fusion and uncoating in a cell-free system.

Authors:  Shakti Narayan; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.